Franklin Resources Inc Krystal Biotech, Inc. Transaction History

Franklin Resources Inc

$334 Billion
Q3 2024

A detailed history of Franklin Resources Inc transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 243,760 shares of KRYS stock, worth $40.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

243,760

Previous 243,760 -0.0%

Holding current value

$40.2 Million

Previous $44.3 Million -0.0%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$174.7 - $213.66 $10.9 Million - $13.3 Million	62,178 Added 34.24%	243,760 $44.3 Million
Q2 2024 Aug 14, 2024	BUY	$153.12 - $183.64 $7.67 Million - $9.2 Million	50,117 Added 38.12%	181,582 $33.3 Million
Q1 2024 May 13, 2024	BUY	$108.01 - $179.35 $11.3 Million - $18.8 Million	104,919 Added 395.23%	131,465 $23.4 Million
Q4 2023 Feb 09, 2024	BUY	$96.0 - $128.29 $6,528 - $8,723	68 Added 0.26%	26,546 $3.29 Million
Q3 2023 Nov 13, 2023	BUY	$108.51 - $130.22 $1.22 Million - $1.46 Million	11,238 Added 73.74%	26,478 $3.07 Million
Q2 2023 Aug 11, 2023	BUY	$78.48 - $130.32 $832,515 - $1.38 Million	10,608 Added 229.02%	15,240 $1.79 Million
Q4 2022 Feb 10, 2023	BUY	$63.14 - $79.9 $1,578 - $1,997	25 Added 0.54%	4,632 $366,000
Q3 2022 Nov 14, 2022	BUY	$64.85 - $82.4 $73,993 - $94,018	1,141 Added 32.92%	4,607 $321,000
Q2 2022 Aug 11, 2022	SELL	$48.93 - $73.47 $13,260 - $19,910	-271 Reduced 7.25%	3,466 $228,000
Q1 2022 May 13, 2022	BUY	$51.99 - $72.11 $194,286 - $269,475	3,737 New	3,737 $249,000
Q4 2021 Feb 11, 2022	SELL	$39.81 - $88.24 $5.57 Million - $12.4 Million	-140,004 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$62.14 - $81.82 $932,100 - $1.23 Million	15,000 Added 12.0%	140,004 $9.52 Million
Q1 2021 May 13, 2021	BUY	$59.42 - $85.46 $7.43 Million - $10.7 Million	125,004 New	125,004 $9.63 Million

Others Institutions Holding KRYS

# of Institutions

310

Shares Held

24.3M

Call Options Held

483K

Put Options Held

364K

View Full List

About Krystal Biotech, Inc.

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $4.23B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

More about KRYS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Krystal Biotech, Inc. Transaction History